Early effects of mood stabilizers on the Akt/GSK-3β signaling pathway and on cell survival and proliferation

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Psychopharmacology

• Publication date

  2009-05-14

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s00213-009-1551-2PMID 19440698
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics.

  2025cited by this paper
• GSK-3β Gene Expression in Human Postmortem Brain: Regional Distribution, Effects of Age and Suicide

  2009cited by this paper
• Akt/GSK3 signaling in the action of psychotropic drugs.

  2009cited by this paper
• Glycogen synthase kinase-3β gene is associated with antidepressant treatment response in Chinese major depressive disorder

  2008cited by this paper
• Protective effects of olanzapine and haloperidol on serum withdrawal-induced apoptosis in SH-SY5Y cells.

  2008cited by this paper
• Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials.

  2008cited by this paper
• Effects of haloperidol, clozapine and olanzapine on the survival of human neuronal and immune cells in vitro

  2007cited by this paper
• Comprar Pharmacotherapy of Bipolar Disorders | Nicolas Schaad | 9780470058237 | Wiley

  2007cited by this paper
• Alteration in kinase activity but not in protein levels of protein kinase B and glycogen synthase kinase-3beta in ventral prefrontal cortex of depressed suicide victims.

  2007cited by this paper
• Haloperidol and clozapine differentially regulate signals upstream of glycogen synthase kinase 3 in the rat frontal cortex

  2007cited by this paper
• Psychotropic drugs affect Ser9-phosphorylated GSK-3 beta protein levels in rodent frontal cortex.

  2006influential reference
• Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007.

  2006cited by this paper
• Clozapine, a neuroleptic agent, inhibits Akt by counteracting Ca2+/calmodulin in PTEN-negative U-87MG human glioblastoma cells.

  2006cited by this paper
• The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials.

  2005cited by this paper
• Atypical antipsychotics in bipolar depression: potential mechanisms of action.

  2005cited by this paper
• A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation

  2005cited by this paper
• Comparative analysis of the effects of four mood stabilizers in SH-SY5Y cells and in primary neurons.

  2005influential reference
• Olanzapine produces trophic effects in vitro and stimulates phosphorylation of Akt/PKB, ERK1/2, and the mitogen-activated protein kinase p38.

  2004influential reference
• Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers

  2004cited by this paper
• In Vivo Regulation of Glycogen Synthase Kinase-3β (GSK3β) by Serotonergic Activity in Mouse Brain

  2004cited by this paper
• The effects of clozapine on the GSK‐3‐mediated signaling pathway

  2004influential reference
• In vivo regulation of glycogen synthase kinase-3beta (GSK3beta) by serotonergic activity in mouse brain.

  2004cited by this paper
• The glamour and gloom of glycogen synthase kinase-3.

  2004cited by this paper
• Clozapine in treatment-resistant patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder: a naturalistic 48-month follow-up study.

  2003cited by this paper
• Attenuated 5‐HT1A receptor signaling in brains of suicide victims: involvement of adenylyl cyclase, phosphatidylinositol 3‐kinase, Akt and mitogen‐activated protein kinase

  2003cited by this paper
• Atypical antipsychotics and mood stabilization in bipolar disorder

  2003cited by this paper
• Neuroimaging studies of mood disorder effects on the brain.

  2003cited by this paper
• Neuronal glucose metabolism and schizophrenia: therapeutic prospects?

  2003cited by this paper
• Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection.

  2002cited by this paper
• Mood stabilizers, glycogen synthase kinase-3β and cell survival

  2002cited by this paper
• Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium.

  2002cited by this paper
• Mood stabilizers, glycogen synthase kinase-3beta and cell survival.

  2002cited by this paper
• Lithium and valproic acid: parallels and contrasts in diverse signaling contexts.

  2002cited by this paper
• Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway.

  2001cited by this paper
• Protein kinase B (PKB/Akt) – a key regulator of glucose transport?

  2001cited by this paper
• PKB/Akt: a key mediator of cell proliferation, survival and insulin responses?

  2001cited by this paper
• The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling.

  2001cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Olanzapine concentrations in clinical serum and postmortem blood specimens--when does therapeutic become toxic?

  2000cited by this paper
• Clozapine for treatment-refractory schizophrenia, schizoaffective disorder, and psychotic bipolar disorder: a 24-month naturalistic study.

  2000cited by this paper
• Lithium-induced increase in human brain grey matter.

  2000cited by this paper
• A novel evidence of different mechanisms of lithium and valproate neuroprotective action on human SY5Y neuroblastoma cells: caspase-3 dependency.

  2000cited by this paper
• Lithium at 50: have the neuroprotective effects of this unique cation been overlooked?

  1999cited by this paper
• Persistence of haloperidol in human brain tissue.

  1999cited by this paper
• Glycogen synthase kinase-3β, β-catenin, and tau in postmortem bipolar brain

  1999cited by this paper
• Olanzapine serum concentrations in psychiatric patients given standard doses: the influence of comedication.

  1999cited by this paper
• Glycogen synthase kinase-3beta, beta-catenin, and tau in postmortem bipolar brain.

  1999cited by this paper
• Regulation of signal transduction pathways and gene expression by mood stabilizers and antidepressants.

  1999cited by this paper
• Relationship between patient variables and plasma clozapine concentrations: a dosing nomogram.

  1998cited by this paper
• Cellular and Molecular Actions of Lamotrigine: Possible Mechanisms of Efficacy in Bipolar Disorder

  1998cited by this paper
• A molecular mechanism for the effect of lithium on development.

  1996cited by this paper
• Antipsychotics in bipolar disorder.

  1996cited by this paper
• Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells.

  1996cited by this paper
• Dosing strategies and time course of response to antimanic drugs.

  1996cited by this paper
• Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

  1995cited by this paper
• Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group.

  1994cited by this paper
• Efficacy of Divalproex vs Lithium and Placebo in the Treatment of Mania

  1994cited by this paper
• Lithium and brain signal transduction systems.

  1994cited by this paper
• The comparative efficacy of carbamazepine low and high serum level and lithium carbonate in the prophylaxis of affective disorders.

  1993cited by this paper

• Marked alteration of phosphoinositide signaling‐associated molecules in postmortem prefrontal cortex with bipolar disorder

  2024cites this paper
• The Neurobiological Role of Lithium Salts

  2023cites this paper
• Laurdan in live cell imaging: Effect of acquisition settings, cell culture conditions and data analysis on generalized polarization measurements.

  2022cites this paper
• Şizofreni hastalarında CYB mtDNA mutasyonları ve PI3K/AKT/mTOR sinyal yolağındaki genlerin ekspresyon durumu

  2022cites this paper
• [A systematic analysis of neurobiological roles of lithium].

  2022cites this paper
• The use of melatonin to mitigate the adverse metabolic side effects of antipsychotics.

  2021cites this paper
• Depression: An Insight into Heterocyclic and Cyclic Hydrocarbon Compounds Inspired from Natural Sources

  2021cites this paper
• Posttranslational modifications & lithium's therapeutic effect - potential biomarkers for clinical responses in psychiatric & neurodegenerative disorders.

  2021cites this paper
• Spirulina platensis reduces the schizophrenic-like symptoms in rat model by restoring altered APO-E and RTN-4 protein expression in prefrontal cortex.

  2021cites this paper
• Mood Stabilizers: Pharmacology and Biochemistry

  2020cites this paper
• Biological Targets Underlying the Antisuicidal Effects of Lithium

  2020cites this paper
• Extremely Low-Frequency Electromagnetic Fields Increase the Expression of Anagen-Related Molecules in Human Dermal Papilla Cells via GSK-3β/ERK/Akt Signaling Pathway

  2020cites this paper
• Valproic acid upregulates the expression of the p75NTR/sortilin receptor complex to induce neuronal apoptosis

  2020cites this paper
• Comparative psychopharmacology of autism and psychotic-affective disorders suggests new targets for treatment

  2019cites this paper
• Neurotrophic effects of lithium stimulate the reduction of ischemic and neurodegenerative brain damage

  2019cites this paper
• Famotidine has a neuroprotective effect on MK-801 induced toxicity via the Akt/GSK-3β/β-catenin signaling pathway in the SH-SY5Y cell line.

  2019cites this paper
• Lithium effects on serine-threonine kinases activity: High throughput kinomic profiling of lymphoblastoid cell lines from excellent-responders and non-responders bipolar patients

  2018cites this paper
• Association of Protein Kinase B (AKT) DNA Hypermethylation with Maintenance Atypical Antipsychotic Treatment in Patients with Bipolar Disorder

  2018cites this paper
• Accessing Gene Expression in Treatment-Resistant Schizophrenia

  2018cites this paper
• Uncoupling DISC1 × D2R Protein-Protein Interactions Facilitates Latent Inhibition in Disc1-L100P Animal Model of Schizophrenia and Enhances Synaptic Plasticity via D2 Receptors

  2018cites this paper
• Subchronic administration of creatine produces antidepressant-like effect by modulating hippocampal signaling pathway mediated by FNDC5/BDNF/Akt in mice.

  2018cites this paper
• Regulation of Glycogen Content in Astrocytes via Cav-1/PTEN/AKT/GSK-3β Pathway by Three Anti-bipolar Drugs

  2018cites this paper
• Crosstalk between insulin and dopamine signaling: A basis for the metabolic effects of antipsychotic drugs.

  2017cites this paper
• Brain-derived neurotrophic factor signaling plays a role in resilience to stress promoted by isoquinoline in defeated mice.

  2017cites this paper
• Lysine Deacetylation by HDAC6 Regulates the Kinase Activity of AKT in Human Neural Progenitor Cells.

  2017cites this paper
• Olanzapine‐induced early cardiovascular effects are mediated by the biological clock and prevented by melatonin

  2017cites this paper
• Effect Of Therapeutic Lithium Carbonate Doses On Rat Brain Content Of Mood Regulating Neurotransmitters

  2017cites this paper
• Ginsenoside Rg1 Decreases Oxidative Stress and Down-Regulates Akt/mTOR Signalling to Attenuate Cognitive Impairment in Mice and Senescence of Neural Stem Cells Induced by d-Galactose

  2017cites this paper
• A novel pipeline for drug discovery in neuropsychiatric disorders using high-content single-cell screening of signalling network responses ex vivo

  2016cites this paper
• Evaluation of BDNF, Calcium Homeostasis and Cell Growth in Two Putative Disease Reporter Models of Bipolar Disorder

  2016cites this paper
• Involvement of PI3K/Akt/GSK-3β and mTOR in the antidepressant-like effect of atorvastatin in mice.

  2016cites this paper
• Molecular Mechanisms of Depression

  2016cites this paper
• [Neurotrophic effects of lithium stimulate the reduction of ischemic and neurodegenerative brain damage].

  2016cites this paper
• Effects of mood‐stabilizing drugs on dendritic outgrowth and synaptic protein levels in primary hippocampal neurons

  2015cites this paper
• The effects of valproate and olanzapine on the abnormal behavior of diacylglycerol kinase β knockout mice

  2015cites this paper
• Lithium increases platelet serine-9 phosphorylated GSK-3β levels in drug-free bipolar disorder during depressive episodes.

  2015cites this paper
• Subtle Impact of Akt1 and Akt3 on Exploratory Behavior in Gene Targeted Mice

  2015cites this paper
• Phosphoinositide-Dependent Protein Kinase 1 (PDK1) Impact on Schizophrenia Risk and Endophenotype Profile

  2015cites this paper
• Proteomic analysis of rat prefrontal cortex after chronic valproate treatment

  2014cites this paper
• Valproate recovers the inhibitory effect of dexamethasone on the proliferation of the adult dentate gyrus-derived neural precursor cells via GSK-3β and β-catenin pathway.

  2014cites this paper
• Akt2 Gene is Associated with Anxiety and Neuroticism in Humans

  2014cites this paper
• A systematic review of antipsychotic drug effects on human gene expression related to risk factors for cardiovascular disease

  2014cites this paper
• Potential Molecular and Cellular Mechanism of Psychotropic Drugs

  2014cites this paper
• The emerging role of dopamine–glutamate interaction and of the postsynaptic density in bipolar disorder pathophysiology: Implications for treatment

  2014cites this paper
• Spatial and temporal patterns of postsynaptic genes and proteins expression by multiple receptors targeting agents: unraveling the impact of multitargeting approach on dopamine-glutamate mediated synaptic plasticity

  2014cites this paper
• Regulation of GSK-3 Activity as A Shared Mechanism in Psychiatric Disorders

  2014cites this paper
• Therapeutic concentrations of valproate but not amitriptyline increase neuropeptide Y (NPY) expression in the human SH-SY5Y neuroblastoma cell line.

  2013cites this paper
• Akt2 Deficiency is Associated with Anxiety and Depressive Behavior in Mice

  2013cites this paper
• Intracellular pathways of antipsychotic combined therapies: implication for psychiatric disorders treatment.

  2013cites this paper
• Investigating the Effect of Lithium on proliferation and cell cycle progression in tight epithelia cell culture from the distal part of the kidney (A6).

  2013cites this paper
• Evaluation of neurotoxic and neuroprotective pathways affected by antiepileptic drugs in cultured hippocampal neurons.

  2013cites this paper
• The mood stabilizer valproate activates human FGF1 gene promoter through inhibiting HDAC and GSK‐3 activities

  2013cites this paper
• University Medical School of Naples "Federico II" Department of Neuroscience, Reproductive and Odontostomatologic Sciences

  2013cites this paper
• Effects of lithium and carbamazepine on spatial learning and depressive behavior in a rat model of bipolar disorder induced by ouabain.

  2013cites this paper
• Allele‐specific expression of the serotonin transporter and its transcription factors following lamotrigine treatment in vitro

  2013cites this paper
• Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents.

  2012cites this paper
• Review of Pharmacological Treatment in Mood Disorders and Future Directions for Drug Development

  2012cites this paper
• Effects of aripiprazole and clozapine on the treatment of glycolytic carbon in PC12 cells

  2012cites this paper
• Bipolar disorder and cognitive functioning : a two-year naturalistic study

  2012cites this paper
• The Role of Oxidative Stress on Neural TRPC3, TRPC5, TRPC6 Expression and/or Function and Relevance to Bipolar Disorder

  2012cites this paper
• Valproate Alters Dopamine Signaling in Association with Induction of Par-4 Protein Expression

  2012cites this paper
• The administration of olanzapine and fluoxetine has synergistic effects on intracellular survival pathways in the rat brain.

  2012cites this paper
• Genetic overlap between schizophrenia and bipolar disorder: a study with AKT1 gene variants and clinical phenotypes.

  2012cites this paper
• The acute and chronic effects of combined antipsychotic-mood stabilizing treatment on the expression of cortical and striatal postsynaptic density genes.

  2011cites this paper
• Promoting Treatment Adherence in Patients with Bipolar Disorder: Consider Your Patients' Perspectives and Goals When Choosing Interventions

  2011cites this paper
• The Role of Glutathione Metabolism in the Neuroprotective Effect of Mood Stabilizers

  2011cites this paper
• Enhanced catecholamine release in mice expressing PKB/SGK-resistant GSK3

  2011cites this paper
• Genetic and pharmacological evidence for schizophrenia‐related Disc1 interaction with GSK‐3

  2011cites this paper
• Association study of Nogo‐related genes with schizophrenia in a Japanese case–control sample

  2011cites this paper
• Peripheral profiling analysis for bipolar disorder reveals markers associated with reduced cell survival

  2011cites this paper
• Effects of acute and chronic treatment elicited by lamotrigine on behavior, energy metabolism, neurotrophins and signaling cascades in rats.

  2011cites this paper
• Dr. Gilmore Replies

  2010cites this paper
• Drs. Christian Kieling, Renata Kieling, and Rohde Reply.

  2010cites this paper
• New Therapeutic Targets for Mood Disorders

  2010cites this paper
• Activation of Akt signaling in rat brain by intracerebroventricular injection of ouabain: a rat model for mania.

  2010cites this paper
• Impairment of phosphatidylinositol 3-kinase signaling in schizophrenia: state or trait?

  2010cites this paper
• Association of AKT1 gene variants and protein expression in both schizophrenia and bipolar disorder

  2010cites this paper
• Depressive relapse after vagal nerve stimulator explantation.

  2010cites this paper
• Is Glycogen Synthase Kinase-3 a Central Modulator in Mood Regulation?

  2010cites this paper
• Dr. Kéri Replies.

  2010cites this paper
• The Neuropeptide VGF Is Reduced in Human Bipolar Postmortem Brain and Contributes to Some of the Behavioral and Molecular Effects of Lithium

  2010influential citation
• Hyperactivity and Enhanced Curiosity of Mice Expressing PKB/SGK-resistant Glycogen Synthase Kinase-3 (GSK-3)

  2006cites this paper
• Send Orders of Reprints at Reprints@benthamscience.org the Wnt Pathway in Mood Disorders

  year unknowncites this paper